Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Miguel Darío Prieto"'
Autor:
Adriana Navas, Lina Giraldo-Parra, Miguel Darío Prieto, Juliana Cabrera, María Adelaida Gómez
Publikováno v:
BMC Immunology, Vol 20, Iss 1, Pp 1-8 (2019)
Abstract Background Human peripheral blood mononuclear cells (PBMCs) are extensively used for research of immune cell functions, identification of biomarkers and development of diagnostics and therapeutics for human diseases, among others. The assump
Externí odkaz:
https://doaj.org/article/b0164ab2becc4510bc1b283b5bb8f5d6
Autor:
Alejandra Maria Del Castillo, Maria del Mar Castro, Alexandra Cossio, Jonny Alejandro García Luna, Domiciano Rincón, Ruth Mabel Castillo, Miguel Darío Prieto, David Esteban Rebellón-Sánchez, Andrés Navarro, Neal Alexander
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 107:662-668
Cutaneous leishmaniasis (CL) primarily affects people in remote settings with limited access to health services. mHealth tools offer an opportunity to overcome knowledge gaps about clinical response to treatment. We evaluated the validity of the Guar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6f70f198f53208e4cf4b4978701fbe5
https://doi.org/10.4269/ajtmh.22-0164
https://doi.org/10.4269/ajtmh.22-0164
Autor:
Miguel Dario Prieto, Jiah Jang, Alessandro N Franciosi, Yossef Av-Gay, Horacio Bach, Scott J Tebbutt, Bradley S Quon
Publikováno v:
PLoS ONE, Vol 17, Iss 12, p e0278296 (2022)
BackgroundIndividuals with cystic fibrosis have an elevated lifetime risk of colonization, infection, and disease caused by nontuberculous mycobacteria. A prior study involving non-cystic fibrosis individuals reported a gene expression signature asso
Externí odkaz:
https://doaj.org/article/19016dfc43e643bdad2f3edf2735880f
Autor:
Deninson Alejandro Vargas, Miguel Dario Prieto, Alvaro José Martínez-Valencia, Alexandra Cossio, Karl E. V. Burgess, Richard J.S. Burchmore, María Adelaida Gómez
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Control of cutaneous leishmaniasis (CL) in the Americas is dependent on chemotherapy with parenteral pentavalent antimonials. High rates of treatment failure urge the search for predictive and prognostic markers of therapeutic responsiveness. In this
Externí odkaz:
https://doaj.org/article/8f2d52434058407c80a3373ff9012b82